NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Exclusive: In open letter, 225 groups describe home secretary’s plan to overhaul asylum system as ‘cruel and ‘ruthless’Read More